Inventor
MARKOTAN THOMAS P
US34 patents
⚠️ This page may combine multiple inventors who share the name “MARKOTAN THOMAS P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DIMENSIONAL PHARM INC
19 patentsUS6037356AMar 14, 2000
Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
DIMENSIONAL PHARM INC67 citations96
US6706021B2Mar 16, 2004
Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
DIMENSIONAL PHARM INC18 citations92
US6566379B1May 20, 2003
Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
DIMENSIONAL PHARM INC13 citations92
US6521663B2Feb 18, 2003
Aminoguanidinyl- and Alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors
DIMENSIONAL PHARM INC18 citations92
US6350764B2Feb 26, 2002
Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
DIMENSIONAL PHARM INC15 citations92
US6235778B1May 22, 2001
Aminoguanidines and alkoxyguanidines as protease inhibitors
DIMENSIONAL PHARM INC17 citations92
US6204263B1Mar 20, 2001
Pyrazinone protease inhibitors
DIMENSIONAL PHARM INC21 citations92
US6900231B2May 31, 2005
Aminopyridyl-substituted phenyl acetamides as protease inhibitors
DIMENSIONAL PHARM INC15 citations84
US6472399B2Oct 29, 2002
Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
DIMENSIONAL PHARM INC13 citations82
US6245763B1Jun 12, 2001
Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
DIMENSIONAL PHARM INC13 citations82
US6706765B2Mar 16, 2004
Aminoguanidines and alkoxyguanidines as protease inhibitors
DIMENSIONAL PHARM INC12 citations81
US6730783B2May 4, 2004
Process for preparing aminoguanidines and alkoxyguanidines as protease inhibitors
DIMENSIONAL PHARM INC9 citations74
US6514978B2Feb 4, 2003
Thromboresistant materials incorporating pyrazinone protease inhibitors
DIMENSIONAL PHARM INC11 citations74
US6417161B1Jul 9, 2002
Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
DIMENSIONAL PHARM INC9 citations74
US6344486B1Feb 5, 2002
Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
DIMENSIONAL PHARM INC9 citations74
US6344466B2Feb 5, 2002
Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protease inhibitors
DIMENSIONAL PHARM INC13 citations74
US6638931B1Oct 28, 2003
Aminoguanidines and alkoxyguanidines as protease inhibitors
DIMENSIONAL PHARM INC11 citations73
US6518310B2Feb 11, 2003
Aminoguanidines and alkoxyguanidines as protease inhibitors
DIMENSIONAL PHARM INC9 citations73
US6855722B2Feb 15, 2005
Substituted indoles and their use as integrin antagonists
DIMENSIONAL PHARM INC10 citations69
REGENERON PHARMA
4 patentsUS9950076B2Apr 24, 2018
Maytansinoid derivatives, conjugates thereof, and methods of use
REGENERON PHARMA34 citations94
US10463749B2Nov 5, 2019
Maytansinoid derivatives, conjugates thereof, and methods of use
REGENERON PHARMA4 citations84
US11446389B2Sep 20, 2022
Maytansinoid derivatives, conjugates thereof, and methods of use
REGENERON PHARMA1 citations73
US10526344B2Jan 7, 2020
Amino acid acylation reagents and methods of using the same
REGENERON PHARMA0 citations46
JANSSEN PHARMACEUTICA NV
4 patentsUS8030305B2Oct 4, 2011
Triazolopyridazines as kinase modulators
JANSSEN PHARMACEUTICA NV24 citations91
US7662824B2Feb 16, 2010
Acylhydrazones as kinase modulators
JANSSEN PHARMACEUTICA NV2 citations60
US9062048B2Jun 23, 2015
Cyclohexyl-azetidinyl antagonists of CCR2
JANSSEN PHARMACEUTICA NV0 citations52
US7446210B2Nov 4, 2008
Factor Xa compounds
JANSSEN PHARMACEUTICA NV0 citations39